Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

613
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
613
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

321
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
321
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

11.3K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuro-symbolic artificial intelligence in medicine.

Nature biomedical engineering·2026
Same author

Diabetes Technologist: Optimal Use of Technology in Everyday Practice.

Journal of diabetes science and technology·2026
Same author

Real-World Evidence Assessment of the Risk of Nonfatal Stroke in Patients Prescribed SGLT2 Inhibitors.

Stroke research and treatment·2026
Same author

Value and Sustainability of Semi-reusable Patch Pump Therapy in Routine Care: A Prospective Multicentre Study.

Journal of diabetes science and technology·2026
Same author

Smart Pens: Expectations Regarding Use and Functionality From Health Care Providers.

Journal of diabetes science and technology·2026
Same author

Glucose Dysregulation in Hantavirus Infection: A Signal Worth Watching With Continuous Glucose Monitoring.

Journal of diabetes science and technology·2026

Related Experiment Video

Updated: Jul 31, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.9K

Evidence and Diabetes Technology: A Catch-22?

Norbert Hermanns1, Bernd Kulzer1, David C Klonoff2

  • 1Research Institite of the Diabetes Acaemy Mergentheim (FIDAM), Bad Mergentheim, Germany.

Journal of Diabetes Science and Technology
|May 2, 2023
PubMed
Summary

The rapid advancement of diabetes technology outpaces its evaluation, creating a dilemma where new devices may be used without sufficient evidence or safety checks. This paper explores strategies for timely assessment to balance innovation with rigorous evaluation.

Keywords:
CGM systemsdiabetes technologyevidenceglucose monitoringinsulin pens

More Related Videos

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
10:07

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature

Published on: December 26, 2017

13.3K
Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
08:16

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

1.6K

Related Experiment Videos

Last Updated: Jul 31, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.9K
Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
10:07

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature

Published on: December 26, 2017

13.3K
Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
08:16

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

1.6K

Area of Science:

  • Endocrinology
  • Medical Technology
  • Health Informatics

Background:

  • Diabetes technology is rapidly evolving, presenting challenges for timely and adequate evaluation.
  • The gap between technological development and assessment creates a 'Catch 22' situation, risking inadequate evidence for new diabetes devices.
  • Current evaluation methods struggle to keep pace with the dynamic nature of diabetes innovations.

Discussion:

  • Discussing strategies for adapting evaluation frameworks to accommodate the rapid pace of diabetes technology development.
  • Addressing the ethical and practical implications of using diabetes technologies with insufficient evidence.
  • Exploring the need for agile and responsive assessment methodologies in the field of diabetes care.

Key Insights:

  • The dynamic evolution of diabetes technology necessitates a re-evaluation of traditional assessment timelines and methodologies.
  • A proactive approach to evaluating new diabetes technologies is crucial for ensuring patient safety and treatment efficacy.
  • Balancing innovation speed with the requirement for robust evidence is paramount for responsible adoption of diabetes technologies.

Outlook:

  • Developing adaptive evaluation models that can keep pace with technological advancements in diabetes management.
  • Fostering collaboration between developers, regulators, and clinicians to streamline the assessment process.
  • Implementing real-world evidence generation strategies to complement traditional clinical trials for diabetes technologies.